|
Types | Related factors | Function | Reference |
|
Ex vivo genetic modification | | | |
Antiapoptosis | TLR4 | Improved survival of TLR4 knockout murine MSCs | [85, 86] |
AKT | Reduced apoptosis of rat MSCs | [87] |
Hsp-20/Hsp-27 | Enhanced survival of rat MSCs |
[88, 89] |
Bcl-2 | Inhibited cell death of rat MSCs | [90] |
Survivin | Enhanced survival of rat MSCs | [91, 92] |
CCR1/CXCR2 | Improved survival of mouse MSCs | [94] |
Cell adhesion |
PAI-1 | Enhanced survival and adhesion of PAI-1 knockout mouse MSCs | [95] |
tTG | Enhanced cell attachment of rat MSCs | [96, 97] |
ILK | Enhanced cell survival and adhesion of rat MSCs | [98, 99] |
Pretreatment | IGF-1 | Elevated connexin-43 and enhanced prosurvival signals and cardiomyogenic differentiation of mouse MSCs | [69] |
SDF-1 | Suppressed apoptosis, enhanced survival, proliferation, and engraftment of rat MSCs | [70] |
Hsp-70 | Protected against hypoxia-induced apoptosis of rat MSCs | [71] |
PRCR | Enhanced survival, proliferation, and differentiation of rat MSCs | [77–79] |
PMA | Increased adhesion of rat MSCs | [80] |
Atorvastatin | Improved survival of swine MSCs | [82] |
Melatonin | Increased survival of rat MSCs | [83] |
MicroRNA-1 | Enhanced survival and cardiomyocyte differentiation of mouse MSCs | [84] |
MicroRNA-125b | Protected against anoikis in human MSCs | [81] |
Preconditioning | Hypoxia | Expressed and secreted prosurvival and proangiogenic factors from MSCs | [25, 68, 72–76] |
|